Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study

Journal of Infectious Diseases

Volumn 212, Issue 7, 2015, Pages 1100-1110

  Abraham, Alison G ^a   Darilay, Annie ^c   McKay, Heather ^a   Margolick, Joseph B ^a   Estrella, Michelle M ^b   Palella, Frank J ^d   Bolan, Robert ^e   Rinaldo, Charles R ^f   Jacobson, Lisa P ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ASTRAZENECA   (United Kingdom)

^d NORTHWESTERN UNIVERSITY   (United States)

^e LOS ANGELES LGBT CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

chronic kidney disease; glomerular filtration rate; HIV infection; immune activation; inflammatory markers

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; CD14 ANTIGEN; CD27 ANTIGEN; CREATININE; GLYCOPROTEIN GP 130; INTERLEUKIN 2 RECEPTOR ALPHA; IOHEXOL; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; EXPLORATORY RESEARCH; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN URINE LEVEL; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; FACTOR ANALYSIS; HIV INFECTIONS; MALE HOMOSEXUALITY; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOMARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FACTOR ANALYSIS, STATISTICAL; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84943372252     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv159     Document Type: Article

References (48)

1. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-4.
2. Wright SC, Jewett A, Mitsuyasu R, Bonavida B. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988; 141:99-104.
3. Gage JR, Breen EC, Echeverri A, et al. Human herpesvirus 8-encoded interleukin 6 activates HIV-1 in the U1 monocytic cell line. AIDS 1999; 13:1851-5.
4. Henderson AJ, Zou X, Calame KL. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995; 69:5337-44.
5. Ito M, Baba M, Sato A, et al. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro. Biochem Biophys Res Commun 1989; 158:307-12.
6. Rodger AJ, Fox Z, Lundgren JD, et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 2009; 200: 973-83.
7. Descamps-Latscha B, Herbelin A, Nguyen AT, et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995; 154:882-92.
8. Spoto B, Leonardis D, Parlongo RM, et al. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis 2012; 22:981-8.
9. Stenvinkel P. New insights on inflammation in chronic kidney diseasegenetic and non-genetic factors. Nephrol Ther 2006; 2:111-9.
10. Shankar A, Sun L, Klein BE, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011; 80:1231-8.
11. Stinghen AE, Bucharles S, Riella MC, Pecoits-Filho R. Immune mechanisms involved in cardiovascular complications of chronic kidney disease. Blood Purif 2010; 29:114-20.
12. Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M. Renal anemia of inflammation: the name is self-explanatory. Blood Purif 2011; 32:220-5.
13. Bruggeman LA, Bark C, Kalayjian RC. HIV and the Kidney. Curr Infect Dis Rep 2009; 11:479-85.
14. Gardner LI, Holmberg SD, Williamson JM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:203-9.
15. Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol 2004; 61:1-6.
16. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-85.
17. Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIVassociated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003; 139:214-26.
18. Leventhal JS, Ross MJ. Pathogenesis of HIV-associated nephropathy. Semin Nephrol 2008; 28:523-34.
19. Lucas GM, Mehta SH, Atta MG, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21:2435-43.
20. Naicker S, Fabian J. Risk factors for the development of chronic kidney disease with HIV/AIDS. Clin Nephrol 2010; 74(suppl 1):S51-6.
21. Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002; 61:195-202.
22. Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39:1199-206.
23. Margolick JB, Jacobson LP, Schwartz GJ, et al. Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection. PLoS One 2014; 9:e86311.
24. Ng DK, Jacobson LP, Brown TT, et al. HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection. AIDS 2014; 28:377-86.
25. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-8.
26. Caliendo AM, Valsamakis A, Zhou Y, et al. Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol 2006; 44: 1726-32.
27. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20:629-37.
28. Schwartz GJ, Furth S, Cole SR, Warady B, Munoz A. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 2006; 69:2070-7.
29. Ng DK, Schwartz GJ, Jacobson LP, et al. Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney Int 2011; 80:423-30.
30. Abraham AG, Munoz A, Furth SL, Warady B, Schwartz GJ. Extracellular volume and glomerular filtration rate in children with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:741-7.
31. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 1978; 93:62-6.
32. Osberg IM, Hammond KB. A solution to the problem of bilirubin interference with the kinetic Jaffe method for serum creatinine. Clin Chem 1978; 24:1196-7.
33. Wada NI, Jacobson LP, Margolick JB, et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 2015; 29:463-71.
34. Hultin LE, Menendez FA, Hultin PM, et al. Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. Cytometry B Clin Cytom 2007; 72:249-55.
35. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1-150.
36. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
37. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-90.
38. Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011; 204:1227-36.
39. Baker JV, Hullsiek KH, Singh A, et al. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS 2014; 28:831-40.
40. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013; 382:1525-33.
41. Bemelmans MH, van Tits LJ, Buurman WA. Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 1996; 16:1-11.
42. Bemelmans MH, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 1993; 150:2007-17.
43. Kopp JB, Nelson GW, Sampath K, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22:2129-37.
44. Nichols B, Jog P, Lee JH, et al. Innate immunity pathways regulate the nephropathy gene apolipoprotein L1. Kidney Int 2015; 87:332-42.
45. Taylor HE, Khatua AK, Popik W. The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol 2014; 88:592-603.
46. Ross MJ, Fan C, Ross MD, et al. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 2006; 42:1-11.
47. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11:152-76.
48. Kimmel PL, Cohen DJ, Abraham AA, Bodi I, Schwartz AM, Phillips TM. Upregulation of MHC class II, interferon-alpha and interferongamma receptor protein expression in HIV-associated nephropathy. Nephrol Dial Transplant 2003; 18:285-92.